LSV Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,900
Closed -$126K – 865
2024
Q1
$126K Sell
1,900
-900
-32% -$55.5K ﹤0.01% 823
2023
Q4
$159K Hold
2,800
– – ﹤0.01% 817
2023
Q3
$153K Sell
2,800
-4,700
-63% -$279K ﹤0.01% 811
2023
Q2
$505K Sell
7,500
-2,303
-23% -$140K ﹤0.01% 752
2023
Q1
$505K Hold
9,803
– – ﹤0.01% 731
2022
Q4
$451K Buy
+9,803
New +$459K ﹤0.01% 736

Other funds holding LMAT

LSV Asset Management's LMAT Position: Q2 2024 in Review

LSV Asset Management sold out of LeMaitre Vascular (LMAT) in Q2 2024, closing a stake of 1,900 shares — an estimated $126K sold.

LSV Asset Management first reported a position in LMAT in Q4 2022 and held it in 6 quarters. The position peaked at $505K in Q2 2023. 262 funds tracked by Wall St. Rank hold LMAT as of Q2 2024.

  • LSV Asset Management reported no remaining LeMaitre Vascular position as of Q2 2024 after selling out during the quarter.
  • LSV Asset Management sold 1,900 LeMaitre Vascular shares in Q2 2024, an estimated $126K.
  • LSV Asset Management first reported a position in LeMaitre Vascular in Q4 2022 and held it in 6 quarters.
  • LSV Asset Management's LeMaitre Vascular position peaked at $505K in Q2 2023.
  • 262 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2024.

Based on LSV Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.